Oncogenomics, Queensland Institute of Medical Research, Herston, Queensland, Australia.
PLoS One. 2011;6(7):e22513. doi: 10.1371/journal.pone.0022513. Epub 2011 Jul 28.
Esophageal adenocarcinoma (EAC) has become a major concern in Western countries due to rapid rises in incidence coupled with very poor survival rates. One of the key risk factors for the development of this cancer is the presence of Barrett's esophagus (BE), which is believed to form in response to repeated gastro-esophageal reflux. In this study we performed comparative, genome-wide expression profiling (using Illumina whole-genome Beadarrays) on total RNA extracted from esophageal biopsy tissues from individuals with EAC, BE (in the absence of EAC) and those with normal squamous epithelium. We combined these data with publically accessible raw data from three similar studies to investigate key gene and ontology differences between these three tissue states. The results support the deduction that BE is a tissue with enhanced glycoprotein synthesis machinery (DPP4, ATP2A3, AGR2) designed to provide strong mucosal defenses aimed at resisting gastro-esophageal reflux. EAC exhibits the enhanced extracellular matrix remodeling (collagens, IGFBP7, PLAU) effects expected in an aggressive form of cancer, as well as evidence of reduced expression of genes associated with mucosal (MUC6, CA2, TFF1) and xenobiotic (AKR1C2, AKR1B10) defenses. When our results are compared to previous whole-genome expression profiling studies keratin, mucin, annexin and trefoil factor gene groups are the most frequently represented differentially expressed gene families. Eleven genes identified here are also represented in at least 3 other profiling studies. We used these genes to discriminate between squamous epithelium, BE and EAC within the two largest cohorts using a support vector machine leave one out cross validation (LOOCV) analysis. While this method was satisfactory for discriminating squamous epithelium and BE, it demonstrates the need for more detailed investigations into profiling changes between BE and EAC.
食管腺癌(EAC)在西方国家已成为一个主要关注点,因为其发病率迅速上升,同时生存率非常低。这种癌症的一个关键危险因素是存在巴雷特食管(BE),它被认为是对反复胃食管反流的反应而形成的。在这项研究中,我们对来自 EAC、无 EAC 的 BE 和正常鳞状上皮的食管活检组织中的总 RNA 进行了比较性的、全基因组表达谱分析(使用 Illumina 全基因组 Beadarrays)。我们将这些数据与三个类似研究中公开获得的原始数据结合起来,研究了这三种组织状态之间的关键基因和本体差异。结果支持了这样的推断,即 BE 是一种具有增强糖蛋白合成机制(DPP4、ATP2A3、AGR2)的组织,旨在提供强大的黏膜防御,以抵抗胃食管反流。EAC 表现出预期的侵袭性癌症的增强细胞外基质重塑(胶原、IGFBP7、PLAU)效应,以及与黏膜(MUC6、CA2、TFF1)和外源性(AKR1C2、AKR1B10)防御相关的基因表达降低的证据。当我们将这些结果与之前的全基因组表达谱研究进行比较时,角蛋白、粘蛋白、膜联蛋白和三叶因子基因族是最常代表差异表达基因家族。这里鉴定的 11 个基因也代表了至少 3 个其他分析中的基因。我们使用这些基因,通过支持向量机留一法交叉验证(LOOCV)分析,在两个最大的队列中区分鳞状上皮、BE 和 EAC。虽然这种方法足以区分鳞状上皮和 BE,但它表明需要对 BE 和 EAC 之间的分析变化进行更详细的研究。